BIA
CLDX icon

Barry Investment Advisors’s Celldex Therapeutics CLDX Stock Holding History

Barry Investment Advisors’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-667
Closed -$2K – 74
2018
Q4 		$2K Hold
667
– – ﹤0.01% 73
2018
Q3 		$5K Hold
667
– – ﹤0.01% 74
2018
Q2 		$5K Hold
667
– – ﹤0.01% 71
2018
Q1 		$23K Hold
667
– – 0.01% 69
2017
Q4 		$28K Hold
667
– – 0.01% 70
2017
Q3 		$29K Hold
667
– – 0.01% 69
2017
Q2 		$25K Hold
667
– – 0.01% 66
2017
Q1 		$36K Sell
667
-600
-47% -$31.2K 0.01% 71
2016
Q4 		$67K Hold
1,267
– – 0.02% 70
2016
Q3 		$77K Buy
+1,267
New +$78.9K 0.03% 71

Other funds holding CLDX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $410M AUM 71.81% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return